There are a number of challenges facing the field in 2020: developing new therapies with manufacturing in mind, managing public expectations, understanding changing regulatory frameworks, and finding investors who understand the importance of manufacturing in the value of a therapy. The Medicine Maker has explored the ingenious solutions emerging to take cell and gene therapy to the next level.
For more articles and information from the Medicine Maker visit- https://themedicinemaker.com/manufacture/advanced-medicine
Interested in Patient Centric Cell Therapy Supply Chain Summit 2020? Click here to request a copy of this year's official Program Agenda
Please note: That all fields marked with an asterisk (*) are required.